发明名称 |
Osteoclast inhibitors such as zoledronic acid for low back pain treatment |
摘要 |
Methods for the safe administration of imidazole or imidazolium compounds, and conditions that may be treated by these methods, are described herein. |
申请公布号 |
US9289441(B2) |
申请公布日期 |
2016.03.22 |
申请号 |
US201514639013 |
申请日期 |
2015.03.04 |
申请人 |
ANTECIP BIOVENTURES II LLC |
发明人 |
Tabuteau Herriot;Karppinen Jaro I. |
分类号 |
A61K31/66;A61K31/675;A61K31/663 |
主分类号 |
A61K31/66 |
代理机构 |
K&L Gates LLP |
代理人 |
K&L Gates LLP ;Cullman Louis C.;Johnson Brent A. |
主权项 |
1. A method of treating Modic changes type I, comprising administering an osteoclast inhibitor to a mammal in need thereof, wherein the mammal experiences pain relief three months after the osteoclast inhibitor is administered; and
wherein the osteoclast inhibitor is risedronic acid, cimadronic acid, or etidronic acid. |
地址 |
New York NY US |